Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan H Kessler

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Genome Medicine|May 26, 2017
Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillanceCornelis J M Melief, Jan H Kessler
Anti-Cancer Drugs|January 16, 2010
Betulinic acid, a natural compound with potent anticancer effectsFranziska B Mullauer, Jan H Kessler, Jan Paul Medema
Plos One|April 29, 2009
Betulin is a potent anti-tumor agent that is enhanced by cholesterolFranziska B Mullauer, Jan H Kessler, Jan Paul Medema
Apoptosis : an International Journal on Programmed Cell Death|December 31, 2008
Betulinic acid induces cytochrome c release and apoptosis in a Bax/Bak-independent, permeability transition pore dependent fashionFranziska B Mullauer, Jan H Kessler, Jan Paul Medema
Cancer Letters|December 16, 2006
Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer typesJan H Kessler, Franziska B Mullauer, Guido M de Roo, et al.
Current Stem Cell Research & Therapy|December 10, 2015
Betulinic Acid Kills Colon Cancer Stem CellsLisette Potze, Simone di Franco, Jan H Kessler, et al.
Current Protocols in Immunology|April 25, 2008
Competition-based cellular peptide binding assay for HLA class IJan H Kessler, Willemien E Benckhuijsen, Tuna Mutis, et al.
Anti-Cancer Drugs|January 26, 2011
Betulinic acid delivered in liposomes reduces growth of human lung and colon cancers in mice without causing systemic toxicityFranziska B Mullauer, Louis van Bloois, Joost B Daalhuisen, et al.
Human Immunology|February 1, 2003
Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptidesJan H Kessler, Bregje Mommaas, Tuna Mutis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapyMarieke Griffioen, Jan H Kessler, Martina Borghi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Genome Medicine|May 26, 2017
Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillanceCornelis J M Melief, Jan H Kessler
Anti-Cancer Drugs|January 16, 2010
Betulinic acid, a natural compound with potent anticancer effectsFranziska B Mullauer, Jan H Kessler, Jan Paul Medema
Plos One|April 29, 2009
Betulin is a potent anti-tumor agent that is enhanced by cholesterolFranziska B Mullauer, Jan H Kessler, Jan Paul Medema
Apoptosis : an International Journal on Programmed Cell Death|December 31, 2008
Betulinic acid induces cytochrome c release and apoptosis in a Bax/Bak-independent, permeability transition pore dependent fashionFranziska B Mullauer, Jan H Kessler, Jan Paul Medema
Cancer Letters|December 16, 2006
Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer typesJan H Kessler, Franziska B Mullauer, Guido M de Roo, et al.
Current Stem Cell Research & Therapy|December 10, 2015
Betulinic Acid Kills Colon Cancer Stem CellsLisette Potze, Simone di Franco, Jan H Kessler, et al.
Current Protocols in Immunology|April 25, 2008
Competition-based cellular peptide binding assay for HLA class IJan H Kessler, Willemien E Benckhuijsen, Tuna Mutis, et al.
Anti-Cancer Drugs|January 26, 2011
Betulinic acid delivered in liposomes reduces growth of human lung and colon cancers in mice without causing systemic toxicityFranziska B Mullauer, Louis van Bloois, Joost B Daalhuisen, et al.
Human Immunology|February 1, 2003
Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptidesJan H Kessler, Bregje Mommaas, Tuna Mutis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapyMarieke Griffioen, Jan H Kessler, Martina Borghi, et al.
Pageof 2